LORI SHAKOUR: Open Payments
NPI 1003537408 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 81 payments from 15 companies in 2025. Trend: 2023 $588 · 2024 $899 · 2025 $1,323
Food & beverage: $1,323
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $332 |
| Galderma Laboratories, L.P. | 6 | $222 |
| PFIZER INC. | 10 | $149 |
| Lilly USA, LLC | 8 | $109 |
| Regeneron Healthcare Solutions, Inc. | 6 | $103 |
| Arcutis Biotherapeutics, Inc. | 6 | $98 |
| Amgen Inc. | 5 | $86 |
| UCB, Inc. | 3 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Incyte Corporation | 2 | $33 |
Products named: SKYRIZI, NEMLUVIO, CIBINQO, DUPIXENT, Zoryve, RINVOQ, Otezla, TALTZ.
Industry payments across NJ — which companies pay providers there.
